Qingdao Jiulong Biomedicine Co., Ltd. was established on November 16, 1998, mainly engaged in the research, production and sales of heparin sodium (the first choice for surgical anticoagulant drugs) and chondroitin sulfate sodium RAW materials. In recent years, it has also developed enoxaparin sodium, daheparin sodium, heparin sulfate, delpolysaccharide and other raw materials.

　　Our company is the first heparin sodium API in China that has passed FDA certification, and is also the enterprise with two heparin sodium API production workshops that have passed FDA certification in China. The process technology of heparin sodium and chondroitin sulfate API were both identified as "international leading level" by the expert group organized by Qingdao Science and Technology Bureau. Since 2011, the quality of heparin sodium API has ranked first in the world, the quantity of heparin sodium API has ranked first in China, and the export ranking has ranked top five in the domestic industry.